Modified docetaxel, cisplatin and fluorouracil therapy as the first-line treatment for patients with recurrent/metastatic squamous cell carcinoma of the head and neck cancer: a retrospective study


Demirci N. S. , AKSOY S., ÖZDEMİR N., Erdem G. U. , Ozcelik M., Tanrikulu E., ...Daha Fazla

CURRENT MEDICAL RESEARCH AND OPINION, cilt.33, ss.401-407, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 33 Konu: 3
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1080/03007995.2016.1257984
  • Dergi Adı: CURRENT MEDICAL RESEARCH AND OPINION
  • Sayfa Sayıları: ss.401-407

Özet

Aim: Modified docetaxel, cisplatin, and 5-fluorouracil (mDCF) therapy has been shown to be a well tolerated and highly effective regimen for metastatic gastric carcinoma. Herein we investigated the effectiveness of the mDCF combination as the first-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (HNSCC).